Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hirsch

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
The Journal of Experimental Medicine|March 18, 2018
Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signalsChun Wang, Susan Hockerman, E Jon Jacobsen, et al.
Plos Neglected Tropical Diseases|June 1, 2023
The leishmaniases in Kenya: A scoping reviewGrace Grifferty, Hugh Shirley, Katherine O'Brien, et al.
Biochemical and Biophysical Research Communications|May 4, 2010
Expression, purification, and characterization of TYK-2 kinase domain, a member of the Janus kinase familyBrian Korniski, Arthur J Wittwer, Thomas L Emmons, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 19, 2010
A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammationRobert J Mourey, Barry L Burnette, Sarah J Brustkern, et al.
Biochemistry|June 6, 2009
Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804Li Xing, Huey S Shieh, Shaun R Selness, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2009
Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translationHeidi R Hope, Gary D Anderson, Barry L Burnette, et al.
Protein Expression and Purification|September 29, 2009
Expression, purification, characterization and crystallization of non- and phosphorylated states of JAK2 and JAK3 kinase domainTroii Hall, Thomas L Emmons, Jill E Chrencik, et al.
Biochimica Et Biophysica Acta|July 31, 2002
Examination of the kinetic mechanism of mitogen-activated protein kinase activated protein kinase-2John F Schindler, Andrew Godbey, William F Hood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2017
Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T CellsDaniel T MacLeod, Jeyaraj Antony, Aaron J Martin, et al.
Genes & Development|June 26, 2015
Corrigendum: Myc and SAGA rewire an alternative splicing network during early somatic cell reprogrammingCalley L Hirsch, Zeynep Coban Akdemir, Li Wang, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
The Journal of Experimental Medicine|March 18, 2018
Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signalsChun Wang, Susan Hockerman, E Jon Jacobsen, et al.
Plos Neglected Tropical Diseases|June 1, 2023
The leishmaniases in Kenya: A scoping reviewGrace Grifferty, Hugh Shirley, Katherine O'Brien, et al.
Biochemical and Biophysical Research Communications|May 4, 2010
Expression, purification, and characterization of TYK-2 kinase domain, a member of the Janus kinase familyBrian Korniski, Arthur J Wittwer, Thomas L Emmons, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 19, 2010
A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammationRobert J Mourey, Barry L Burnette, Sarah J Brustkern, et al.
Biochemistry|June 6, 2009
Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804Li Xing, Huey S Shieh, Shaun R Selness, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2009
Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translationHeidi R Hope, Gary D Anderson, Barry L Burnette, et al.
Protein Expression and Purification|September 29, 2009
Expression, purification, characterization and crystallization of non- and phosphorylated states of JAK2 and JAK3 kinase domainTroii Hall, Thomas L Emmons, Jill E Chrencik, et al.
Biochimica Et Biophysica Acta|July 31, 2002
Examination of the kinetic mechanism of mitogen-activated protein kinase activated protein kinase-2John F Schindler, Andrew Godbey, William F Hood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2017
Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T CellsDaniel T MacLeod, Jeyaraj Antony, Aaron J Martin, et al.
Genes & Development|June 26, 2015
Corrigendum: Myc and SAGA rewire an alternative splicing network during early somatic cell reprogrammingCalley L Hirsch, Zeynep Coban Akdemir, Li Wang, et al.
Pageof 34